As it examines the deaths of more than 150 children due to acute renal injury, Indonesia’s food and drug regulator announced on Monday that it has revoked the syrup medicine production licenses of two local enterprises for breaking manufacturing guidelines (AKI). The decision was made by the BPOM agency after Indonesia temporarily banned the sale of certain syrup-based medications and …